SGCB and hydrops fetalis: Recent studies have shown that the nitric oxide (NO)-soluble guanylate cyclase (sGC)-cyclic guanosine monophosphate (cGMP) pathway plays a crucial role in regulating cardiovascular function and serves as a novel target for the treatment of HF [4].